afabicin: Clinical Trials

7 trials of afabicin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 terminated. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Not yet recruiting 1
Phase 22Completed 1, Terminated 1

Follow afabicin: new trials by email Literature Review of afabicin trials Research Report on afabicin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Renal Impairment Pharmacokinetics (PK) Trial of Afabicin
Afabicin Oral, Afabicin IV - Renal Impairment
Phase 1Not yet recruitingDebiopharm International SA602026-09-012026-09-22
Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
Afabicin, Cefazolin, Vancomycin - Bone or Joint Infection
Phase 2TerminatedDebiopharm International SA672019-02-202026-09-09
A Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects
Debio 1450, Itraconazole - Healthy Participants
Phase 1CompletedDebiopharm International SA202017-06-142017-10-18
Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
Debio 1450 - Bone Diseases, Infectious
Phase 1CompletedDebiopharm International SA172016-04-012017-10-18
Study of Debio 1450 for Bacterial Skin Infections
Debio 1450 IV, Debio 1450 Oral, Linezolid - Bacterial Infections
Phase 2CompletedDebiopharm International SA3302015-05-012019-11-13
A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers
Placebo IV Solution, Debio 1450 IV Solution, Placebo Tablet or Capsule - Bacterial Infections
Phase 1CompletedDebiopharm International SA702014-08-012015-02-25
A Single Dose Study of Debio 1450 in Healthy Subjects
Debio 1450, Placebo - Bacterial Infections
Phase 1CompletedDebiopharm International SA482014-06-012014-10-23

Conditions studied

Bacterial Infections (3)  ·  Bone Diseases, Infectious (1)  ·  Renal Insufficiency (1)

Sponsors

Debiopharm International SA (7)

Countries

United States (4)  ·  Georgia (1)  ·  Germany (1)  ·  South Africa (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Azra Hussaini, MD (1)  ·  Frederick Wittke, MD (1)

Results publications

PMID 30559136, PMID 32747361

NIH funding

2017 (1)